[Retracted] Production of interleukin‑4 in CD133+ cervical cancer stem cells promotes resistance to apoptosis and initiates tumor growth.
Following the publication of this article, an investigation conducted internally within our Department has revealed that the data published in Fig.  5a are not reproducible. Consequently, confidence in the conclusions drawn from the reported results in the paper has been undermined and, as a result, all authors involved have unanimously agreed to the retraction of this article. All authors recognize the seriousness of this issue and apologize unreservedly to the editors, reviewers and readers. We are also in the process of examining other studies in the paper. We sincerely regret that this study has been compromised, and are committed to rapidly correcting the public record and implementing practices to prevent any recurrence of such a situation in the future. [the original article was published in Molecular Medicine Reports 13: 5068-5076, 2016; DOI: 10.3892/mmr.2016.5195].
Department of Gynecology, The Affiliated Zhongshan Hospital of Dalian University, Dalian, Liaoning 116001, P.R. China.
Chun-Tao
CT
Liu
Department of Gynecology, The Affiliated Zhongshan Hospital of Dalian University, Dalian, Liaoning 116001, P.R. China.
Ying
Y
Xin
Department of Gynecology, The Affiliated Zhongshan Hospital of Dalian University, Dalian, Liaoning 116001, P.R. China.
Chun-Yan
CY
Tong
Department of Gynecology, The Affiliated Zhongshan Hospital of Dalian University, Dalian, Liaoning 116001, P.R. China.
Bing
B
Li
Department of Gynecology, The Affiliated Zhongshan Hospital of Dalian University, Dalian, Liaoning 116001, P.R. China.
Hong-Li
HL
Bao
Department of Gynecology, The Affiliated Zhongshan Hospital of Dalian University, Dalian, Liaoning 116001, P.R. China.
Cai-Yun
CY
Zhang
Department of Gynecology, The Affiliated Zhongshan Hospital of Dalian University, Dalian, Liaoning 116001, P.R. China.
Xue-Hui
XH
Wang